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ORIGINAL ARTICLE
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Abstract
Context: There is a need for the discovery of novel natural remedies to prevent and treat
metabolic disorders such as hyperglycemia, type II non-insulin-dependent diabetes mellitus,
and obesity. Several Achillea species have been utilized for centuries all around the world and
are generally considered effective as hypoglycemic.
Objective: Considering the ethnobotanical uses of Achillea genus, we evaluated the in vitro
inhibitory activity of Achillea tenorii Grande (Asteraceae) extract on a-glucosidase, which is a
valuable target to prevent and treat metabolic disorders. We also tested its antioxidant activity.
Moreover, the phytochemical profile was discussed from a chemotaxonomic point of view.
Materials and methods: In vitro a-glucosidase inhibition of crude ethanolic extract obtained
from the aerial parts was assayed as well as the in vitro antioxidant activity (ABTS, DPPH, and
FRAP-FZ tests) was measured. The extract was characterized from a phytochemical point of
view by means of spectroscopic analysis.
Results: The extract results endowed with a-glucosidase inhibitory activity (IC50 32 mg/mL) with
a particular mechanism of action definable as un-competitive, which differed from the
mechanism observed for the best-known a-glucosidase inhibitor (acarbose and miglitol). In
addition, a considerable antioxidant potential has been found for A. tenorii extract, which
resulted mainly constituted by phenolic compounds such as caffeoylquinic acids and
flavonoids.
Discussion and conclusions: These results suggest the potential of A. tenorii as a possible natural
remedy to prevent and treat metabolic disorders of carbohydrates.
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Introduction
Achillea tenorii Grande (Asteraceae) [syn. A. virescens (Fenzl)
Heimerl subsp. virescens (Grande) Ba¨ssler] is considered a
member of A. nobilis aggregate. There are many endemic
species in the genus Achillea, among them A. tenorii, whose
presence is restricted to certain areas; it grows from 900 up to
2200 m (a.s.l.) in stony mountains and high mountain pastures
of central and southern Apennines (Conti et al., 2005). As
regards its morphological characteristics, this plant is a scapose
hemicryptophyte perennial herb with pinnatisect leaves,
narrow segments, and small capitula bearing white-yellowish
ligulate florets accompanied by pubescent and glandular
bracts. Notably, A. tenorii differs from other species of the
Achillea genus for the presence of stolons, short floral tube,
and dark bracts (Pignatti, 1982). Several Achillea species have
been utilized in ethnopharmacology for centuries all around
the world. Although the use as traditional remedy depends
considerably on national traditions, Achillea species are
generally considered effective as tonic, anti-inflammatory,
spasmolytic, diaphoretic, diuretic, hypoglycemic, anti-bleed-
ing, and wound healing (Nemeth & Bernath, 2008). A large
number of phytochemical and pharmacological studies were
carried out on different species of Achillea genus and recent
findings have also confirmed some traditional uses but until
now no data are reported for A. tenorii.
Objective
In this work, we elucidated the phytochemical composition of
A. tenorii polar fraction, discussing the results from a
chemotaxonomic point of view. Furthermore, in order to
provide information on the potential of A. tenorii hydroalco-
holic extract as an antioxidant, we performed ABTS, DPPH,
and FRAP-FZ tests. Moreover, considering the ethnobotanical
use of different Achillea species in the treatment of diabetes
as well as different studies on the hypoglycemic effect of
these plants (Al-Hindawi et al., 1989; Yazdanparast et al.,
2007), we have tested the inhibitory activity of A. tenorii
extract on a-glucosidase, a membrane-bound enzyme of the
GH31 family, which plays a key role in carbohydrate
absorption. Indeed, this enzyme catalyzes the final step in
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the digestive process of carbohydrates, by the hydrolysis of
polysaccharides into glucose and related monosaccharides,
which can be easily absorbed (El-Kaissi & Sherbeeni, 2011).
Therefore, this enzyme may be considered a valuable target in
order to reduce the postprandial glucose blood rise and
a-glucosidase inhibitors may be useful to prevent and treat
metabolic disorders such as type II non-insulin-dependent
diabetes mellitus, obesity, and hyperglycemia (Baron, 1998;
Taylor & Johnson, 1996).
Materials and methods
General
NMR spectra were recorded on Varian Mercury 300 MHz
instrument using CD3OD or D2O as deuterated solvents;
the chemical shifts were expressed in ppm from tetramethyl-
silane (TMS).
MS spectra were performed on a Q-TOF MICRO spec-
trometer (Waters, Manchester, UK) equipped with an ESI
source, which was operated in the negative and/or positive ion
mode. The flow rate of sample infusion was 10 mL/min with
100 acquisitions per spectrum. Data were analyzed using the
MassLynx software developed by Waters (Manchester, UK).
Solvents of RPE grade were purchased from Sigma Aldrich
(Milan, Italy) or Carlo Erba Reagenti (Milan, Italy); silica gel
60 (70–230 mesh ASTM) were from Fluka (Dresden,
Germany); all the other reagents were purchased from Sigma
Aldrich (Milan, Italy).
Plant materials
Plant materials were collected from the Majella National Park
on June 2011 and the botanical identification was performed
by the botanists of the Park (Dr. Mirella Di Cecco and Dr.
Giampiero Ciaschetti). A sample of the studied plant is stored
in our laboratory under the accession number: AT03062011.
Extraction and isolation of polar compounds
Four consecutive extractions were conducted on A. tenorii
aerial parts (400 g) using a mixture of ethanol/water (3 L for
each extraction, 48 h infusion time). In particular, for the first
extraction, ethanol 96% v/v was used, while in the following
three extractions, ethanol 80% v/v was used. The obtained
extracts were collected separately and, after evaporation of
the organic solvent, the extracts were frozen and lyophilized.
From the first to the fourth extraction: 10.12, 1.87, 1.52, and
0.89 g of crude extracts were obtained.
The chromatographic screening on TLC revealed the
abundance of phenolic compounds, also evidenced by a
strong positive reaction with the FeCl3 spray reagent. The four
extracts appeared similar from a qualitative point of view
while quantitative differences were evident, in particular the
third and fourth extracts were constituted mainly of com-
pounds with Rf.50.6, while the first extract showed the whole
molecular pattern and, for this reason, it was subjected to
fractionations and tested for biological activity.
Repeated silica gel column chromatography was conducted
on 2.05 g of the first extract using different solvent mixtures:
butanol saturated with water, mixtures of chloroform/metha-
nol at various percentages, with or without previous saturation
with CO2, and increasing the polarity during the chromato-
graphic run. This separation procedure yielded fractions
containing: a mixture of caffeoylquinic acids (chlorogenic
acid (1) and neochlorogenic acid (2) 2:1, (92.9 mg)), caffeic
acid (3) (13.2 mg), apigenin-7-O-b-D-glucopyranoside (6)
(17.3 mg) and luteolin-7-O-b-D-glucopyranoside (7)
(29.1 mg), from the more polar fractions, and the respective
flavone aglycones apigenin (4) (8.2 mg), luteolin (5) (5.6 mg)
from the less polar fractions (Figure 1). All the isolated
substances were identified by comparison of experimental
spectroscopic data with those reported in the literature and
also by direct comparison with standard substances available
in our laboratory.
3-O-Caffeoylquinic acid (chlorogenic acid) (1): 1H NMR
(300 MHz, CD3OD) : 7.55 (1H, d, J¼ 15.9 Hz, Hb), 7.04
(1H, d, J¼ 1.9 Hz, H20), 6.95 (1H, dd, J¼ 8.2, 1.9 Hz, H60),
6.77 (1H, d, J¼ 8.2 Hz, H50), 6.26 (1H, d, J¼ 15.9 Hz, Ha),
5.33 (1H, td, J¼ 9.1, 4.5 Hz, H3), 4.22–4.12 (1H, m, H4),
3.72 (1H, dd, J¼ 8.5, 3.1 Hz, H5), 2.29–1.97 (4H, m, H2, H6).
13C NMR 75 MHz, D2O, : 179.7 (COOH quin.), 168.9 (COO






















1) Chlorogenic acid: R= H; R'= caffeoyl
2) Neochlorogenic acid: R= caffeoyl; R'= H
caffeoyl
4) Apigenin: R=H; R'=H
5) Luteolin: R=H; R'=OH
6) Apigenin-7-O-β-D-glucopyranoside: R=Glc; R'=H





























Figure 1. Identified compounds of polar fraction.
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(C60), 116.2 (C50), 115.3 (C20), 114.2 (Ca), 77.1 (C1), 75.9
(C3), 74.3 (C4), 72.9 (C5), 38.9 (C6), 37.0 (C2). ESI-MS: m/z
[M + Na]+¼ 377.02; m/z [MH]¼ 352.85.
5-O-Caffeoylquinic acid (neochlorogenic acid) (2): 1H
NMR 300 MHz D2O : 7.31 (1H, d, J¼ 15.9 Hz, Hb), 6.76
(1H, d, J¼ 1.8 Hz, H20); 6.64 (1H, d, J¼ 1.8 Hz, H60); 6.06
(1H, d, J¼ 15.9 Hz, Ha); 5.05 (1H, s, H5); 4.08 (1H, bd, H3);
3.81 (1H, bd, H4); 2.00 (1H, m, H6); 1.886 (1H, m, H2). 13C
NMR 75 MHz, D2O : 180.8 (COOH quin.), 169.8 (COO
caff.), 147.9 (C40), 146.9 (Cb), 145.09 (C30), 127.8 (C10),
123.5 (C60), 117.05 (C50), 115.96 (C20), 115.4 (Ca), 77.59
(C1), 73.73 (C4), 72.49 (C5), 71.9 (C3), 38.9 (C6), 37.9 (C2).
ESI-MS: m/z [M + Na]+¼ 377.02; m/z [MH]¼ 352.85.
Caffeic acid (3): 1H NMR (300 MHz, CD3OD) : 7.54
(1H, d, J¼ 15.9 Hz, Hb), 7.04 (1H, d, J¼ 1.9 Hz, H2), 6.93
(1H, dd, J¼ 8.2; 1.9 Hz, H6), 6.78 (1H, d, J¼ 8.2 Hz, H5),
6.22 (1H, d, J¼ 15.9 Hz, Ha). 13C NMR (75 MHz, CD3OD)
: 171.08 (COOH), 149.36 (Cb), 147.06 (C4), 146.69 (C3),
127.72 (C1), 122.87 (C6), 116.44 (C5), 115.42 (C2), 115.05
(Ca). ESI-MS: m/z 179.05 [MH].
Apigenin (4): 1H NMR (300 MHz, CD3OD) : 7.84 (2H, d,
J¼ 8.6 Hz, H20, H60), 7.12 (2H, d, J¼ 8.5 Hz, H30, H50), 6.82
(1H, s, H3), 6.68 (1H, d, J¼ 2.0 Hz, H8), 6.57 (1H, d J¼ 2.0 Hz,
H6). 13C NMR (75 MHz, CD3OD) d: 182.0 (C4), 165.7 (C7),
163.2 (C5), 162.5 (C2), 162.2 (C40), 157.6 (C9), 129.1 (C20,
C60), 122.0 (C10), 116.8 (C30, C50), 105.3 (C10), 103.3 (C3),
99.0 (C6), 94.6 (C8). ESI-MS: m/z 269.03 [MH].
Luteolin (5): 1H NMR (300 MHz, CD3OD) : 7.41 (1H,
dd, J¼ 8; 2 Hz, H60), 7.37 (1H, d, J¼ 2 Hz, H60), 6.90 (1H, d,
J¼ 8.2 Hz, H50), 6.68 (1H, s, H3), 6.47 (1H, d, J¼ 1.8 Hz,
H8), 6.28 (1H, d, J¼ 1.8 Hz, H6). 13C NMR (75 MHz,
CD3OD) : 182.4 (C4), 164.7 (C7), 164.4 (C2), 162.5 (C5),
150.4 (C40), 146.6 (C30), 123.1 (C60), 119.5 (C10), 116.8
(C50), 104.7 (C10), 99.6 (C6), 96.2 (C8). ESI-MS: m/z 287.15
[MH]; m/z 309.27 [M + Na]+.
Apigenin-7-O-b-D-glucopyranoside (cosmetin) (6): 1H
NMR (300 MHz, CD3OD) : 7.85 (2H, d, J¼ 8.5 Hz, H30,
H50), 6.92 (2H, d, J¼ 8.6 Hz, H20, H60), 6.79 (1H, s, H8), 6.62
(1H, s, H3), 6.48 (1H, s, H6), 5.07 (1H, d, J¼ 7.0 Hz, H100),
4.12–3.50 (overlapped sugar signals). 13C NMR (75 MHz,
CD3OD)  184.0 (C4), 166.7 (C7), 164.7 (C5), 163.8 (C2),
162.8 (C40), 158.9 (C9), 129.6 (C20, C60), 123.0 (C10), 117.0
(C30, C50), 107.0 (C10), 105.3 (C3), 104.1 (C6), 101.6 (C100),
78.5 (C500), 77.3 (C300), 74.7 (C200), 71.3 (C400), 62.5 (C600).
ESI-MS: m/z 431.26 [MH].
Luteolin-7-O-b-D-glucopyranoside (cynaroside) (7): 1H
NMR (300 MHz, CD3OD) : 7.42 (2H, bd, J¼ 8.2, H60, H20),
6.89 (1H, d, J¼ 8.5, H50), 6.79 (1H, bs, H8), 6.68 (1H, bs,
H3), 6.47 (1H, s, H6), 5.09 (1H, d, J¼ 7.2, H100). 13C NMR
(75 MHz, CD3OD)  184.2 (C4), 166.7 (C7), 164.8 (C2),
162.8 (C5), 151.0 (C40), 147.1 (C30), 124.1 (C60), 120.5 (C10),
117.1 (C50), 104.2 (C10), 101.2 (C100), 99.5 (C6), 96.1 (C8),
77.9 (C500), 75.4 (C300), 74.7 (C200), 72.9 (C400), 62.51 (C600).
ESI-MS: m/z 471.14 [M + Na]+; m/z 447.23 [MH].
Biological activities
DPPH and ABTS
DPPH assay was performed according to Brand-Williams
et al. (1995), with some modifications. Different stock
solutions of plant extract were prepared in ethanol/water
(20% v/v) to have different final concentrations (5, 10, 30, 50,
and 100mg/mL in the assay) in order to calculate the IC50
value. DPPH methanol solution was added to different
concentrations of extract and allowed to react at room
temperature. Assay was performed in a final volume of
2.0 mL. After 20 min, the absorbance (Abs) values were
measured at 517 nm and converted into the percentage
antioxidant activity using the following formula:
Scavenging capacity % 1  ðAbssample=AbscontrolÞ  100
 
DPPH solution plus methanol only was used as a negative
control, Trolox (Tr) at different concentrations (from 5 to
50 mM) was used as a positive control and Tr was used for the
calculation of total antioxidant capacity (TAC), expressed in
mmol Tr eq/g of extract.
ABTS assay was performed according to Arnao et al.
(2001), with some modifications. ABTS+ radical was
generated by mixing a 2.0 mM ABTS solution with 7.0 mM
K2S2O8 and incubating in the dark for 24 h at room tempera-
ture. Before usage, the ABTS+ solution was diluted (1–25 mL
methanol) to get an Abs of 0.7 at 734 nm. 0.9 mL of the diluted
ABTS+ solution to 10 mL of Tr (positive control) or extract
stock solutions was added to have a final concentrations of 5,
10, 15, 20, 50, and 100 mg/mL. The Abs at 734 nm was
recorded after 1.0 min. The IC50 values both in ABTS and in
DPPH were calculated by linear regression of plots, where x-
axis represents sample or Tr concentrations, and y-axis
represents the average percentage of scavenging capacity
from three independent experiments with duplicate samples.
FRAP-ferrozine assay
The colorimetric method was used to determine the capacity
of the extract to reduce the ferric ions (Fe3+) in ferrous ions
(Fe2+), which was obtained following the method proposed by
Beker et al. (2010) with some modifications.
A calibration curve was created for the complex Fe2+/
ferrozine (FZ) using increasing concentrations of FeCl2 (from
0 to 100mM) and 0.5 mM FZ (in distilled water) in a final
volume of 1 mL. 200mL of a previously prepared mixture
containing FeCl3 (1 mM) and FZ (5 mM) were added to
100 mL of Tr (concentrations range from 6.0 to 300 mM) or
extract (concentrations range from 10 to 50 mg/mL). The Abs
was read in the microplate reader at 570 nm after 5 min
incubation at room temperature. The Abs of FeCl3/FZ mixture
was subtracted from that obtained with Tr or samples. In order
to build a dose–response curve for Tr, the Fe2+ amount
produced by different concentrations of this antioxidant was
calculated from the calibration curve.
Based on the dose–response curve, FRAP unit, which
represent the sample amount capable of producing 100 mM
Fe2+, was calculated. TAC (mmol Tr/g of extract) value was
calculated comparing the result obtained from the extract to
that of Tr. The assay was performed in duplicate and repeated
three times.
-Glucosidase inhibitory assay
a-Glucosidase from Saccharomyces cerevisiae (E.C. 3.2.1.20)
was purchased from Sigma Aldrich Co (St. Louis, MO) and
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a-glucosidase inhibition assay was performed according to Li
et al. (2005) with slight modifications. 3 mU of enzyme (one
unit will liberate 1.0 mmol of D-glucose from p-nitrophenyl-
a-D-glucopyranoside per min at pH 6.8 at 37 C) prepared in
0.1 M phosphate buffer pH 6.8 were incubated for 10 min with
test samples at different concentrations: from 5 to 100 mg/mL
or pure standard compounds (luteolin, chlorogenic acid) from
0.01 to 1.5 mM, to a final volume of 100 mL. The synthetic
substrate p-nitrophenyl-a-D-glucopyranoside (p-NPG), pre-
pared in buffer, was added to the preincubated mixture at a
final concentration of 2 mM, to start the reaction with a final
volume of 200mL. After 5 min (t5), 50 mL of NaOH 0.1 M was
added and the absorbance at 405 nm was recorded in the
microplate reader under a constant temperature of 30 C. The
initial absorbance of the samples at t0 was established through
their blanks (containing all the reagents except for the
enzyme). The specific activity of the enzyme referred to
p-NPG was 14 U/mg as reported by the purchaser.
The IC50 value (concentration necessary for 50% inhib-
ition) was calculated by constructing a logarithmic curve
showing sample concentrations on x-axes and the percentage
inhibition on y-axes. The percentage of inhibition of enzyme
activity was calculated by the following formula:






A negative control was obtained by adding water instead of
samples and DAbs values were calculated as Abs t10Abs t0
and referred to 1 min.
The Lineweaver–Burk (L–B) plot was constructed in order
to calculate the kinetic parameters (Km expressed in mM and
vmax in nkat) of the enzymatic reaction with and without
samples at the IC50 concentrations. Different p-NPG concen-
trations were used in the range 2–0.25 mM; the rate
of the enzymatic reaction expressed in mkat was
calculated from DAbs min, considering p-nitrophenolate "
at 405 nm¼ 18.5 mM1 cm1 and light path length¼ 0.8 cm.
Statistical analysis
Values are expressed as the mean ± SD of three independent
experiments with samples in triplicate. Statistical analysis was
performed using Graph Pad Prism 4 software (GraphPad Inc.,
La Jolla, CA) by one-way analysis of variance (ANOVA),
considering significant differences at p-values50.05.
Results and discussion
The polar fraction of A. tenorii consisted predominantly by
phenolic compounds. In particular, a high amount (about 1%
w/w) of two caffeoyl-quinic acid derivatives, namely
chlorogenic acid (1) (Bai et al., 2011), neochlorogenic acid
(2) (dos Santos et al., 2004) and free caffeic acid (3) (Bai
et al., 2011) were obtained. Additionally, flavonoid aglycones,
apigenin (4) and luteolin (5), together with their respective 7-
O-b-D-glucosides, cosmetin (6) and cynaroside (7) (Ivancheva
& Kuzmanov, 1986; Oyama & Kondo, 2004; Park, 2007; Van
Loo et al., 1986; Wada, 1985) were identified. Apigenin and
its glucoside as well as luteolin were previously detected in
other species of this genus, in particular A. millefolium
(Huo et al., 2013) and A. nobilis (Marchart et al., 2003).
Conversely, unlike in other Achillea species, no glucuronide
derivatives of flavones were identified in A. tenorii following
the reported fractionation methodology. These metabolites
seem to be highly conserved in this genus and they were
identified both in A. millefolium (Benedek et al., 2007) and in
A. nobilis (Solomko et al., 1978), which belong to the same
group as A. tenorii, as well as in A. collina (Kasaj et al., 2001)
and A. cartilaginea (Zapesochnaya & Ban’kovskii, 1976),
which belong to a different group. The apparent absence of
glucuronide derivatives, or their presence in trace amount,
may be dependent on the phenological phase of the plant’s
development but may also be a metabolic characteristic of the
species A. tenorii. This aspect should be confirmed with
further studies.
Regarding the biological activity, A. tenorii hydroalcoholic
extracts were endowed with considerable antioxidant proper-
ties, showing positive results in all tests performed (DPPH,
ABTS, and FRAP-FZ) (Table 1). This activity is probably
attributable to the high content of secondary metabolites
derived from the shikimate pathway, in particular, flavonoids
and phenolic acids. Indeed, these kinds of natural compounds
are endowed with strong antiradical activity due to their
characteristic conjugated ring structure and their hydrogen
donor ability, conferred by the presence of hydroxyl groups.
As highlighted by the results obtained using the ABTS (IC50
22.49 ± 2.01 mg/mL) and DPPH (IC50 31.41 ± 3.13 mg/mL)
tests, the extract has an interesting electron donor and
hydrogen donor potential. These results, along with the
aforementioned phenolic composition, are comparable with
those reported for other Achillea species (the IC50 value
ranges from 55.0 to 33.0 mg/mL) (Ardestani & Yazdanparast,
2007; Barıs¸ et al., 2011; Candana et al., 2003). In order to
determine the reducing power, the FRAP-Ferrozine (FZ) test
was also performed. This assay represents an improved form
of the original FRAP test (Benzie & Strain, 1996). In
particular, the Fe2+–FZ complex is stable and spectrophoto-
metrically detectable over a wide range of pH, this makes the
assay performable at physiological pH instead of the acidic
one required by the original method. The TAC value, obtained
for A. tenorii using the FRAP-FZ test (0.53 mmol Tr eq/g), is
comparable with that reported for Camellia sinensis
(0.63 mmol Tr eq/g) and Salvia officinalis (0.31 mmol Tr
eq/g) extracts (Beker et al., 2010), which are well known for
their antioxidant activity.
Statistical analysis was performed on TAC values obtained
from ABTS, DPPH, and FRAP-FZ and the extract was
particularly active in the ABTS test (p50.01) while no
difference was evident between results obtained using DPPH
and FRAP-FZ.
Table 1. Antioxidant activity of A. tenorii hydroalcoholic extract was
measured with ABTS, DPPH, and FRAP-FZ tests and expressed in IC50
values (mg/mL) or FRAP unit, which represent the sample amount which
produces 100 mM Fe2+ and total antioxidant capacity (TAC) expressed in
mmol Tr eq/g of extract.
ABTS DPPH FRAP-FZ
IC50 TAC IC50 TAC FRAP unit TAC
22.49 ± 2.01 1.50 31.41 ± 3.13 0.71 21.56 ± 1.51 0.53
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Moreover, according to our results (Figure 2) extracts of
A. tenorii are endowed with an interesting a-glucosidase
inhibitory activity (the IC50 value is 32.07 ± 2.2 mg/mL).
Hypothesizing that the activity exhibited by the extract was
probably due to flavonoids, in particular luteolin, which is a
well-known a-glucosidase inhibitor (Ha et al., 2012) the
purified compound was tested, giving an IC50 value of
47 ± 1.5 mM (13.23mg/mL) (Figure 3). Moreover, considering
the high content of chlorogenic acid recognized in the extract,
pure standard of this compound was also tested and an
activity considerably lower than luteolin was found (IC50
1.3 ± 0.2 mM; 461 mg/ml).
The variation of a-glucosidase kinetic parameters (Km and
vmax), induced by A. tenorii extracts, was also investigated.
Fitting the inhibition data using a Lineweaver–Burk (L–B)
plot indicated an un-competitive mechanism of action. As
shown in Figure 4, treating the enzyme with the extract
altered both kinetic parameters (Table 2). This uncommon
kind of inhibition occurs when the inhibitor binds only the
enzyme–substrate complex preventing products formation.
Luteolin has been previously reported as an un-competitive
a-glucosidase inhibitor (Ha et al., 2012), in fact when the
enzyme is treated with this compound, vmax is altered while
no change in the Km value is recorded. This suggests that
compounds, other than luteolin, present in the extract, may
contribute to the total inhibitory activity of A. tenorii
conferring the un-competitive mechanism of inhibition.
Conversely, voglibose and miglitol, the best known a-gluco-
sidase inhibitors, act through a competitive mechanism of
action, binding in the active site of the enzyme; this
mechanism is characteristic for most of the a-glucosidase
inhibitors which are definable as sugar mimetics (Kato et al.,
2012). It is noteworthy that un-competitive inhibitors are
considered more promising than competitive inhibitors as
therapeutic agents, considering that their activity is not lost as
the concentration of substrate builds up (Westley & Westley,
1996).
Conclusions
The overall phenolic composition of A. tenorii is comparable to
that reported for the genus Achillea and a high amount of
polyphenols (caffeoylquinic acids and flavonoids) was isolated
from the extract. However, from a chemotaxonomic point of
view the absence of glucuronide derivatives of flavonoids,
mainly apigenine derivatives, which represent metabolites
highly conserved in this genus is noteworthy.
Regarding the biological activity, A. tenorii can be
considered as an accessible source of natural antioxidants.
Moreover the combination of the antioxidant and a-glucosi-
dase inhibitory activities makes this plant particularly promis-
ing in the management of diabetes mellitus, being able to affect






















Figure 2. IC50 plot of a-glucosidase inhibition calculated using 2 mM



















chlorogenic acid luteolin Achillea extract
Figure 3. a-Glucosidase inhibition of chlorogenic acid, luteolin, and

















Figure 4. Lineweaver–Burk plot of a-glucosidase and p-NPG, without
(g) and with (m) Achilea tenorii extract at the IC50 concentration.
Table 2. Kinetic parameters of f a-glucosidase and p-NPG
without (negative control) and with Achilea tenorii extract
at the IC50 concentration (32 mg/mL). Km was expressed in




Km (mM) 0.37 0.021
vmax (nKat) 0.56 0.028
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the importance of novel a-glucosidase inhibitors are of
growing importance considering that acarbose and miglitol,
which are the only drugs used in therapy, are characterized by
several side effects such as gastrointestinal complaints
(Kato et al., 2012). In addition, a-glucosidase inhibitors are
of particular interest due to their potential as antiviral and anti-
metastatic agents (Elbein, 1991).
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